Youth Nominated Support Team (YST)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05558332 |
Recruitment Status :
Not yet recruiting
First Posted : September 28, 2022
Last Update Posted : February 26, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Psychosis Suicide Health Care Utilization Family Members | Behavioral: Youth-Nominated Support Teams for CHR | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 70 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | One group will recieve the adapted YST treatment (YST-CHR) and the other group will receive treatment as usual. Participants receiving the existing treatment will be offered YST-CHR after the study is over if appropriate |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Youth Nominated Support Team for Suicidal Adolescents at Clinical High Risk for Psychosis |
Estimated Study Start Date : | September 2024 |
Estimated Primary Completion Date : | March 2025 |
Estimated Study Completion Date : | December 2025 |
Arm | Intervention/treatment |
---|---|
Experimental: YST-CHR Group
This group will recieve the new adapted YST treatment (YST-CHR). Clinicians will administer this treatment. Neither group will be blind.
|
Behavioral: Youth-Nominated Support Teams for CHR
Intervention for adolescents aimed at preventing, reducing, and/or managing suicidal thoughts and behaviors. YST-CHR is an "add on" to the treatment and therapy they are already receiving. Study clinicians will administer the adapted YST treatment manual to participants, aimed at improving suicidal risk. |
No Intervention: Treatment as usual
This group will receive their usual therapy/treatment as usual.
|
- Social Connectedness [ Time Frame: 3-months after intervention ]Connectedness will be measured with the 5-item Thwarted Belongingness subscale of the Interpersonal Needs Questionnaire. Scores range from 15-105 and a higher score indicates lower social connectedness.
- Increased Hope [ Time Frame: 3-months after intervention ]Hopelessness will be measured with the 4-item Beck Hopelessness Scale (BHS). Hopelessness may be a very sensitive indicator of subsequent suicide risk, particularly among youth with psychosis. The total BHS score is a sum of item responses from 0 to 20 such that higher scores reflect higher levels of hopelessness. Scores greater than 14 identify severe hopelessness.
- Treatment Engagement [ Time Frame: 3-months after intervention ]This will be measured using clinic records of appointment attendance to determine number of therapy sessions attended.
- Severity and Intensity of Suicidal Ideation [ Time Frame: Baseline, 6 weeks after intervention, and 3 months after intervention ]This will be drawn from the Columbia Suicide Severity Rating Scale (C-SSRS). The scores range from 0 to 25. Higher scores indicate higher suicide risk symptoms.
- Severity and Intensity of Suicidal Ideation [ Time Frame: baseline, 6 weeks after intervention, and 3 months after intervention ]This will also be drawn from the Suicide History of Assessment for People with Psychosis-Spectrum Experiences (SHAPE). This measure is used to query about suicidal thoughts and actions and history with these experiences. It is not scored but used to get a better understanding of the participant's thoughts and feelings related to suicide.
- Interpersonal Conflict [ Time Frame: 3 months after intervention ]Test of Negative Social Exchange (TENSE). Participants score statements on a scale from 0 to 9. Items are summed together to create a composite score. Higher scores on the TENSE indicate higher frequency of negative social exchange.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 12 Years to 25 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- A person with suicidal ideation in the past 3 months or suicidal attempt in the past year
- A person who is receiving or has received treatment for psychosis risk symptoms
- Between the ages of 12-25
Exclusion Criteria:
- Cannot have participated in the first 2 phases of the study (focus groups and adaption of the YST-CHR manual)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05558332
Contact: Jason E Schiffman, PhD | 424-291-2159 | jeschiff@uci.edu | |
Contact: Samantha Jay, MA | 201-452-0343 | sjay1@umbc.edu |
Responsible Party: | Jason Eric Schiffman, Director of Clinical Training, University of California, Irvine |
ClinicalTrials.gov Identifier: | NCT05558332 |
Other Study ID Numbers: |
480 |
First Posted: | September 28, 2022 Key Record Dates |
Last Update Posted: | February 26, 2024 |
Last Verified: | February 2024 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Suicide Psychotic Disorders Mental Disorders |
Self-Injurious Behavior Behavioral Symptoms Schizophrenia Spectrum and Other Psychotic Disorders |